![]() |
|
|
Vol. 291, Issue 2, 725-732, November 1999
Department of Integrative Physiology and The Cardiovascular
Research Institute University of North Texas Health Science Center,
Fort Worth, Texas (L.D.N., D.A.Y., B.A.B., J.L.C.); and Department of
Pharmacology, Louisiana State University Medical Center, Shreveport,
Louisiana (S.C.R.)
Short-term morphine stimulates vagal bradycardia. This led us to
propose the hypothesis that chronically administered morphine would
down-regulate myocardial muscarinic receptor systems. Dogs received
morphine continuously for 2 weeks through an s.c. catheter, and
cellular aspects of parasympathetic control of the heart were examined.
Contrary to expectations, morphine increased muscarinic receptor
density in the right atrium and left ventricle by 17 and 34%,
respectively, with no change in the apparent affinity of the receptor
(KD). Morphine also increased the expression
of the G protein Gi
by 115 and 233%,
respectively, in right atrial and left ventricular sarcolemmal
membranes. Morphine increased ventricular and atrial
Gs
to a much lesser degree (49 and 25%).
Morphine failed to alter basal or maximally stimulated (forskolin plus
MnCl2) adenylate cyclase activity. The maximum cyclase
activation by isoproterenol and the maximum inhibition by carbachol
were similarly unaltered by morphine. Morphine reduced the ventricular but not atrial norepinephrine. Both long- and short-term morphine lowered tissue epinephrine content, suggesting that short-term morphine
reduces extraneuronal uptake. Potential systemic and cellular models
for myocardial adaptation to morphine are proposed, including
sequential sympathetic and parasympathetic compensations.